JP Morgan Chase’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

JP Morgan Chase’s Portfolio BRLI Stock Details BRLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-104,145	Closed	-$4.29M	–	4275
2015 Q2	$4.29M	Buy	+104,145	New	+$3.73M	﹤0.01%	2480
2014 Q1	–	Sell	-33,828	Closed	-$864K	–	4163
2013 Q4	$864K	Buy	33,828 +2,104	+7%	+$64.8K	﹤0.01%	3216
2013 Q3	$948K	Sell	31,724 -6,668	-17%	-$185K	﹤0.01%	3300
2013 Q2	$1.1M	Buy	+38,392	New	+$1.06M	﹤0.01%	3198

Other funds holding BRLI

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

JP Morgan Chase's BRLI Position: Q3 2015 in Review

JP Morgan Chase sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 104,145 shares — an estimated $4.29M sold.

JP Morgan Chase first reported a position in BRLI in Q2 2013 and held it in 4 quarters. The position peaked at $4.29M in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

JP Morgan Chase reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
JP Morgan Chase sold 104,145 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $4.29M.
JP Morgan Chase first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 4 quarters.
JP Morgan Chase's BIO-REFERENCE LABS INC-NEW- position peaked at $4.29M in Q2 2015.
1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on JP Morgan Chase's 13F filing for Q3 2015, filed 13 Nov 2015.